MYLAN 357 (Pentoxifylline 400 mg)
Pill imprint MYLAN 357 has been identified as Pentoxifylline 400 mg.
Pentoxifylline is used in the treatment of intermittent claudication and belongs to the drug class miscellaneous coagulation modifiers. Risk cannot be ruled out during pregnancy. Pentoxifylline 400 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 357 (Pentoxifylline 400 mg)
- 400 mg
- 16.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Miscellaneous coagulation modifiers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- D&C Red No. 30
FD&C Blue No. 2
FD&C Yellow No. 6
hydroxyethyl cellulose (140 mpa.s at 5%)
|NDC Code||Manufacturer / Repackager|
|51079-0889||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
Pentoxifylline is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...